Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

A questionnaire survey on the diagnosis and treatment of Fabry nephropathy in clinical practice: Soo Jeong Choi, Su Hyun Kim, Min Sung Lee et al.; Kidney Res Clin Pract. 2023;42(5):628-638. Published online June 15, 2023; DOI: https://doi.org/10.23876/j.krcp.22.235; Full text PubReader ePub PDF Supplementary Material

Study Protocol

Efficacy and safety of rapid intermittent bolus compared with slow continuous infusion in patients with severe hypernatremia (SALSA II trial): a study protocol for a randomized controlled trial: Ji Young Ryu, Songuk Yoon, Jeonghwan Lee et al.; Kidney Res Clin Pract. 2022;41(4):508-520. Published online April 13, 2022; DOI: https://doi.org/10.23876/j.krcp.21.193
Web of Science 2 Cited By 2; Full text PubReader ePub PDF

Review Articles

Immune mechanisms in the different phases of acute tubular necrosis: Fedor Kundert, Louise Platen, Takamasa Iwakura, Zhibo Zhao, Julian A. Marschner, Hans-Joachim Anders; Kidney Res Clin Pract. 2018;37(3):185-196. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.185
Web of Science 18 Cited By 18; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,531	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,491	C4d Puzzle in ABO-incompatible kidney transplantation
7,884	How should we treat acute kidney injury caused by renal congestion?
34,787	Uremic pruritus: pathophysiology, clinical presentation, and treatments
12,602	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.